Hair Growth Serum OEM Industry Data Report

Executive Summary

The global hair serum market was valued at USD 1.3 billion in 2024 and is projected to reach USD 2.4 billion by 2033, according to Grand View Research (2024). This establishes an addressable finished-product context for Hair Growth Serum OEM programs rather than a measure of contract-manufacturing revenue alone. The gap between the reported starting value and projected endpoint makes formulation, claims, and route-to-market definitions material when interpreting demand.

Hair treatment serums, including hair-loss and regrowth uses, represented 64.6% of the global hair serum market in 2024, according to Grand View Research / Spherical Insights (2024). This means treatment-oriented positioning is the larger documented product segment within the cited serum market. For OEM and private-label buyers, it also makes the boundary between cosmetic care language and therapeutic implication a central product-development issue.

The global cosmetics OEM/ODM market is projected to reach USD 31.71 billion by 2025, with China holding nearly 30% of global share, according to the SEYE Cosmetic Industry Report (2025). This places Hair Growth Serum OEM within a wider outsourced-cosmetics production ecosystem rather than an isolated niche. The China share is relevant to sourcing analysis because it indicates substantial manufacturing presence, not an automatic indicator of any individual supplier’s scale or suitability.

China’s exports of shampoo and related hair-care products rose 16.79% year on year to USD 137 million between January and August 2025, according to the General Administration of Customs of China (2025). Although this trade measure is broader than serum and does not isolate contract manufacturing, it provides a directional indicator of cross-border activity in adjacent hair-care goods. The distinction matters: an export trend cannot be used as a direct proxy for hair-growth-serum sales.

Demand for serums using facial-grade ingredients such as Hyaluronic Acid and Peptides increased 30%, according to Mintel / Technavio (2023). The documented trend supports the relevance of ingredient-led briefs in custom serum development. It does not, however, establish that every ingredient-led claim is acceptable in every destination market.

Methodology & Sources

This white paper uses only the verified dataset supplied for the Light Industry & Daily Use / Hair Growth Serum OEM category. It distinguishes finished hair-serum market evidence, broader cosmetics OEM/ODM evidence, adjacent hair-care trade evidence, regulatory statements, and supplier information; these measures are not treated as interchangeable.

Sources used are Grand View Research, Spherical Insights, Fortune Business Insights, the SEYE Cosmetic Industry Report, the General Administration of Customs of China, EUR-Lex / EcoMundo, the U.S. FDA / American Hair Loss Association, Mintel / Technavio, and EIN Presswire / Desifine Official. Source links are reproduced in the cited tables and reference sentences for auditability. Values are reported as supplied; no averaging, recalculation, or extrapolation has been applied.

Scope note: “Hair Growth Serum OEM” covers outsourced development and manufacturing discussions around hair-growth, anti-hair-loss, regrowth, and strengthening serum briefs. The available dataset does not provide a standalone global revenue figure for this exact OEM subcategory, destination-level serum exports, minimum order quantities, pricing, or supplier-by-supplier market shares. Accordingly, this report treats the wider hair-serum and cosmetics-OEM data as context and retains those boundaries throughout.

Market Overview

The global hair serum market’s reported 2024 value is USD 1.3 billion, with a projected USD 2.4 billion endpoint by 2033, per Grand View Research (2024). This source frames the category through a finished-product market lens, which is useful for assessing the commercial environment in which private-label and custom-manufacturing projects operate. It should not be read as a direct estimate of the Hair Growth Serum OEM segment.

For the same market reference point, estimates range from USD 1.3 billion from Grand View Research to USD 1.304 billion from Spherical Insights for 2024, while Fortune Business Insights reports USD 1.44 billion for 2025, according to the dataset’s divergence note. The values should remain separately attributed rather than consolidated into a single “consensus” number. The cited divergence note identifies inclusion of medicinal versus purely cosmetic hair serums as a reason for variation. In addition, a one-year timing difference can affect comparability, and differing source coverage may place different products or channels inside the reported market boundary.

Hair treatment serums accounted for 64.6% of the global hair serum market in 2024, according to Grand View Research / Spherical Insights (2024). This segment share suggests that treatment-related use cases are a significant organizing category within the underlying market definition. For a manufacturer or buyer, the implication is not that all treatment briefs have equivalent regulatory status; it is that the product brief must be translated into claim language appropriate to the intended market.

The private-label cosmetics market is growing at a CAGR of 5.5%, according to Grand View Research (2024). This broader private-label measure is relevant because custom and private-label hair serum projects sit within outsourced brand-building models. It does not establish a serum-specific private-label growth rate, but it supports separating brand ownership decisions from manufacturing ownership decisions in procurement analysis.

Reported market estimates

Trade & Supply Landscape

China’s shampoo and related hair-care product exports reached USD 137 million between January and August 2025, after a 16.79% year-on-year increase, according to the General Administration of Customs of China (2025). This is the dataset’s direct trade indicator for the supply landscape, although it covers a broader group than hair serums. Its relevance is contextual: it shows movement in adjacent exported hair-care goods while leaving serum-only export value and OEM-only export value unreported.

The global cosmetics OEM/ODM market is projected to reach USD 31.71 billion by 2025, and China holds nearly 30% of global share, according to the SEYE Cosmetic Industry Report (2025). The combined statement supplies a macro-level context for contract production availability. It cannot identify which facilities make hair growth serums, which have capacity available, or how trade flows are allocated by destination, so supplier selection still requires product- and market-specific diligence.

DESIFINE operates a 15,000 m² factory with annual output of 5 million units and holds GMPC and ISO 22716 certifications, according to EIN Presswire / Desifine Official (2024). Within the supplied evidence, this is a manufacturer-specific capacity and quality-system disclosure rather than a measure of market share. It provides a documented production reference point, but it should not be compared directly with the broader export value because the units, coverage, and commercial definitions differ.

The available evidence does not provide destination-country shares, serum-specific customs codes, regional production-cluster totals, or capacity-utilization data. For that reason, the trade chart below presents the reported adjacent hair-care export value only, rather than implying an unverified geographic flow map or supplier ranking.

Adjacent Chinese hair-care exports

Technology & Standards Trends

Hair growth products in the EU are subject to Regulation (EC) No 1223/2009, and claims about follicle stimulation may shift classification to “medicinal,” according to EUR-Lex / EcoMundo (2024). This places the wording of a serum’s intended benefit alongside formulation in the compliance process. For an OEM brief, a product positioned as cosmetic care may require a different claims assessment from one framed around physiological stimulation.

In the United States, Minoxidil and Finasteride are the active ingredients currently identified as FDA-approved for hair growth, while other products are typically classified as cosmetics/cosmeceuticals, according to the U.S. FDA / American Hair Loss Association (2024). The reported distinction makes it inappropriate to transfer a claim strategy mechanically from a cosmetic serum into a drug-associated presentation. Development teams can use the distinction as a decision point for intended positioning, labeling review, and market-specific documentation.

Demand for hair serums featuring facial-grade ingredients such as Hyaluronic Acid and Peptides increased 30%, according to Mintel / Technavio (2023). This trend is commonly described in the dataset as the “skinification” of hair care. Its practical OEM relevance is that an ingredient-led brief may need to connect ingredient selection, substantiation, and permitted claims rather than treating those workstreams as separate marketing exercises.

The data does not provide a verified performance comparison among ingredients, formula stability results, clinical endpoints, or a universal standard for anti-hair-loss efficacy. Therefore, no performance ranking is made here. The available standards evidence supports a compliance-first interpretation of functional scalp-care development, especially where a proposed claim can alter product classification.

Market Landscape / Representative Manufacturers

Cosmax, Intercos, and Kolmar Korea are identified as global cosmetic OEM/ODM participants increasingly investing in functional scalp care, according to Fortune Business Insights (2024). This group is presented as a representative global cluster, not as a ranking by revenue, output, or hair-serum capability. The supplied evidence links these companies to functional scalp-care investment, which makes them relevant reference names for the category’s outsourced-manufacturing landscape.

Cosmax, Intercos, and Kolmar Korea should consequently be read as examples of established international OEM/ODM participation in a broader functional-care direction. The verified dataset supplies no comparable plant sizes, hair-serum volumes, customer lists, or product-performance measures for these companies. A neutral landscape assessment therefore avoids inferring relative advantage from their inclusion alone.

DESIFINE is included in a China-based OEM/ODM cluster because the verified data identifies Guangdong Desifine Biotechnology Co., Ltd. and reports a 15,000 m² factory, annual output of 5 million units, and GMPC and ISO 22716 certifications, according to EIN Presswire / Desifine Official (2024). These are disclosed operating attributes, not evidence that DESIFINE is superior to other suppliers or that its capacity is dedicated to hair growth serum. Its presence in this report reflects the provided representative-brand input and documented manufacturer information.

The landscape is structured around different evidence types: global participants are supported by an investment-direction statement, whereas DESIFINE has supplied facility and certification information. Because no verified supplier market shares or uniform manufacturer metrics are available, a numerical competitive chart would imply precision that the evidence does not support. The matrix below is therefore a non-ranked reference table rather than a performance comparison.

Outlook

Because Grand View Research reports a USD 1.3 billion global hair serum market in 2024 and a USD 2.4 billion projection for 2033, the commercial context for serum-format product programs appears set to remain relevant over the cited horizon. As a result, OEM briefs may increasingly need a clear distinction between a general hair-care serum and a treatment-oriented positioning. This is a scope interpretation of the reported market trajectory, not a forecast of any individual manufacturer’s sales.

Given that treatment serums represented 64.6% of the hair serum market in 2024 and that EU follicle-stimulation claims may shift a product toward medicinal classification, claim governance is likely to remain a decisive development checkpoint. As a result, buyers and manufacturers may need to align intended benefits with destination-market classification before finalizing product communication. The logic follows the documented segment concentration and regulatory boundary, rather than assuming that treatment demand permits therapeutic wording.

Because demand for facial-grade ingredient serums increased 30% in the cited trend evidence, custom formulations may continue to use ingredient-led briefs as a point of product differentiation. As a result, substantiation and claims review become more important companions to ingredient selection, particularly where hair-growth language is contemplated. The dataset does not permit a prediction about which ingredient will prevail, so no ingredient-specific outlook is offered.

Given that the private-label cosmetics market is reported to grow at a CAGR of 5.5%, private-label hair serum propositions may continue to be evaluated within broader outsourced-brand models. As a result, procurement decisions may place greater emphasis on the division of responsibilities between brand owner and manufacturer. This is not a claim that private-label hair serums themselves grow at the same rate; the cited rate belongs to the broader private-label cosmetics market.

Because China’s adjacent hair-care exports increased 16.79% year on year to USD 137 million in the reported period, export readiness may remain relevant to China-based supply discussions. As a result, market-specific documentation and claims discipline can be treated as operational risk controls rather than afterthoughts. The evidence remains adjacent-category trade data, so it cannot establish serum-specific export momentum or destination demand.

Key Data Points

• The global hair serum market was valued at USD 1.3 billion in 2024 and is projected to reach USD 2.4 billion by 2033, according to Grand View Research (2024) (link).
• Hair treatment serums accounted for 64.6% of the global hair serum market in 2024, according to Grand View Research / Spherical Insights (2024) (link).
• The global cosmetics OEM/ODM market is projected to reach USD 31.71 billion by 2025, with China holding nearly 30% of global share, according to the SEYE Cosmetic Industry Report (2025) (link).
• China exported USD 137 million of shampoo and related hair-care products between January and August 2025, a 16.79% year-on-year increase, according to the General Administration of Customs of China (2025) (link).
• Demand for serums containing facial-grade ingredients increased 30%, according to Mintel / Technavio (2023) (link).

FAQ

About HTNXT

HTNXT is a B2B export data platform. This report is presented as a neutral, source-attributed industry analysis and does not rank suppliers or recommend a specific manufacturer. Platform reference: https://www.htnxt.com; Wikidata: Q140226564.